Search
Search Results
##search.searchResults.foundPlural##
-
-
FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients
1010PDF: 581Html: 132 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2503PDF: 824HTML: 17436Fig1 Caligaris: 142Fig.2 Caliga: 175 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
3967PDF: 1100HTML: 1913Fig.1: 202Fig. 2: 101Table 1: 183Table2: 198Table 3: 178 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1610PDF: 621HTML: 2412 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
2939PDF: 988HTML: 3052 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2521PDF: 720HTML: 192 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1335PDF: 1002HTML: 205 -
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
1646PDF: 804Html: 267 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3754PDF: 1401HTML: 8482 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7181PDF: 2344HTML: 1699Table 1.: 181Table 2.: 197Table 3.: 179Table 4.: 177 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1012PDF: 524HTML: 1670Figures: 140Fifures Sanz: 155tables Sanz: 162Untitled: 152 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3613PDF: 1199HTML: 3861Untitled: 181Untitled: 240 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4224PDF: 1444HTML: 1528Untitled: 207 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2242PDF: 933HTML: 7603Untitled: 253Fig2: 162Fig3: 142Fig4: 160 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1094PDF: 996HTML: 171 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
1962PDF: 1154Html: 254 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
2992PDF: 1760HTML: 3534 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2271PDF: 871HTML: 462 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1844PDF: 1040HTML: 552 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2146PDF: 920HTML: 1867 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4304PDF: 1859HTML: 17705 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1172PDF: 546HTML: 2839ATRA induced Reactive Hemophagocytosis: A Case Report: 171 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1854PDF: 702HTML: 677 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2794PDF: 1386HTML: 3037Cover Letter: 179 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1318PDF: 783HTML: 3100 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
886PDF: 324HTML: 162







